Historical record - last NADAC publication: 6/20/2018
Product Information
RYTARY ER 61.25 MG-245 MG CAP is a brand product labeled by Amneal Pharmaceuticals LLC, priced at $3.5009 per EA under NDC 64896066443. Its NADAC has been published 133 times since Feb 17, 2016.
The High Outlier badge above means this manufacturer's average price in the Carbidopa and Levodopa market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
61.25; 245 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
64896066443
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/20/2018
Active Ingredients
CARBIDOPA HYDRATE; LEVODOPAApproval Type
New Drug (NDA)
FDA Application
NDA203312On Market Since
1/12/2015
Pharmacological Classes
Price Statistics
The NADAC for RYTARY ER 61.25 MG-245 MG CAP has been published 133 times since Feb 17, 2016, and over the history we have for it it has risen 25.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5009 per EA |
|---|---|
| All-time high | $3.5009 (Aug 29, 2018) |
| All-time low | $2.7924 (Feb 17, 2016) |
| Median price | $3.1150 |
| Average price | $3.0926 |
| Largest weekly change | +9.9% (May 9, 2018) |
| Weeks tracked | 133 |
| Tracking since | Feb 17, 2016 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RYTARY ER 61.25 MG-245 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for RYTARY ER 61.25 MG-245 MG CAP, manufactured by Amneal Pharmaceuticals LLC, is $3.5009 per EA (NDC 64896066443), effective Aug 29, 2018.
How has the price of RYTARY ER 61.25 MG-245 MG CAP changed over time?
Over the history we have for it, the NADAC for RYTARY ER 61.25 MG-245 MG CAP has risen 25.4%. It has been tracked across 133 weekly CMS publications since Feb 17, 2016.
What are the highest and lowest recorded NADAC prices for RYTARY ER 61.25 MG-245 MG CAP?
Since Feb 17, 2016, the NADAC for RYTARY ER 61.25 MG-245 MG CAP has ranged from a low of $2.7924 (Feb 17, 2016) to a high of $3.5009 (Aug 29, 2018), with a median of $3.1150 per EA.
Are there cheaper alternatives to RYTARY ER 61.25 MG-245 MG CAP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as RYTARY ER 61.25 MG-245 MG CAP, but none are currently priced below it.
Who manufactures RYTARY ER 61.25 MG-245 MG CAP?
RYTARY ER 61.25 MG-245 MG CAP (NDC 64896066443) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification